J E Dalen

Summary

Publications

  1. ncbi Thrombolysis in submassive pulmonary embolism? No
    J E Dalen
    University of Arizona, Tucson, AZ, USA
    J Thromb Haemost 1:1130-2. 2003
  2. ncbi Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis
    James E Dalen
    University of Arizona, 1840 East River Road, Suite 207, Tucson, AZ, USA
    Chest 122:1440-56. 2002
  3. ncbi Pulmonary embolism: what have we learned since Virchow?: treatment and prevention
    James E Dalen
    University of Arizona, Tucson, AZ 85718, USA
    Chest 122:1801-17. 2002
  4. ncbi National Health Insurance: could it work in the US?
    James E Dalen
    University of Arizona, Tucson, USA
    Am J Med 121:553-4. 2008
  5. ncbi Aspirin to prevent heart attack and stroke: what's the right dose?
    James E Dalen
    University of Arizona, Tucson 85718, USA
    Am J Med 119:198-202. 2006
  6. ncbi The moratorium on US medical school enrollment, from 1980 to 2005: what were we thinking?
    James E Dalen
    University of Arizona College of Medicine, USA
    Am J Med 121:e1-2. 2008
  7. ncbi Should patients with venous thromboembolism be screened for thrombophilia?
    James E Dalen
    University of Arizona, 1840 E River Road, Suite 120, Tucson, AZ 85718, USA
    Am J Med 121:458-63. 2008
  8. ncbi Transition from student to clerk to physician: advice for third-year students
    James E Dalen
    University of Arizona Health Sciences Center, 1501 N. Campbell Avenue, Tucson, AZ, 85724, USA
    Curr Cardiol Rep 6:309-10. 2004
  9. ncbi Selective COX-2 Inhibitors, NSAIDs, aspirin, and myocardial infarction
    James E Dalen
    Arch Intern Med 162:1091-2. 2002
  10. ncbi Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Daniel E Singer
    Clinical Epidemiology Unit, Massachusetts General Hospital, Boston, MA 02114, USA
    Chest 133:546S-592S. 2008

Detail Information

Publications24

  1. ncbi Thrombolysis in submassive pulmonary embolism? No
    J E Dalen
    University of Arizona, Tucson, AZ, USA
    J Thromb Haemost 1:1130-2. 2003
  2. ncbi Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis
    James E Dalen
    University of Arizona, 1840 East River Road, Suite 207, Tucson, AZ, USA
    Chest 122:1440-56. 2002
  3. ncbi Pulmonary embolism: what have we learned since Virchow?: treatment and prevention
    James E Dalen
    University of Arizona, Tucson, AZ 85718, USA
    Chest 122:1801-17. 2002
  4. ncbi National Health Insurance: could it work in the US?
    James E Dalen
    University of Arizona, Tucson, USA
    Am J Med 121:553-4. 2008
  5. ncbi Aspirin to prevent heart attack and stroke: what's the right dose?
    James E Dalen
    University of Arizona, Tucson 85718, USA
    Am J Med 119:198-202. 2006
    ..These studies indicate that the most appropriate dose for the primary and secondary prevention of stroke and MI is 160 mg/day...
  6. ncbi The moratorium on US medical school enrollment, from 1980 to 2005: what were we thinking?
    James E Dalen
    University of Arizona College of Medicine, USA
    Am J Med 121:e1-2. 2008
  7. ncbi Should patients with venous thromboembolism be screened for thrombophilia?
    James E Dalen
    University of Arizona, 1840 E River Road, Suite 120, Tucson, AZ 85718, USA
    Am J Med 121:458-63. 2008
    ..On the other hand, idiopathic VTE significantly increases the risk of recurrence in patients with or without thrombophilia...
  8. ncbi Transition from student to clerk to physician: advice for third-year students
    James E Dalen
    University of Arizona Health Sciences Center, 1501 N. Campbell Avenue, Tucson, AZ, 85724, USA
    Curr Cardiol Rep 6:309-10. 2004
  9. ncbi Selective COX-2 Inhibitors, NSAIDs, aspirin, and myocardial infarction
    James E Dalen
    Arch Intern Med 162:1091-2. 2002
  10. ncbi Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Daniel E Singer
    Clinical Epidemiology Unit, Massachusetts General Hospital, Boston, MA 02114, USA
    Chest 133:546S-592S. 2008
    ..However, in patients without contraindications to anticoagulation, we suggest beginning IV heparin or LMWH at presentation (Grade 2C)...
  11. ncbi Aspirin in the prevention of cardiovascular disease in women
    James E Dalen
    N Engl J Med 352:2751-2; author reply 2751-2. 2005
  12. ncbi The uncertain role of thrombolytic therapy in the treatment of pulmonary embolism
    James E Dalen
    Arch Intern Med 162:2521-3. 2002
  13. ncbi Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    Paul D Stein
    St Joseph Mercy Oakland, 44555 Woodward Ave, Suite 107, Pontiac, MI 48341, USA
    Chest 126:600S-608S. 2004
    ..For all patients undergoing IMA bypass grafting without other indication for VKA, we suggest clinicians not use VKA (Grade 2C)...
  14. ncbi Thrombolytic therapy in patients with submassive pulmonary embolism
    James E Dalen
    N Engl J Med 348:357-9; author reply 357-9. 2003
  15. ncbi Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    Daniel E Singer
    Clinical Epidemiology Unit, S50 9, Massachusetts General Hospital, Boston, MA 02114, USA
    Chest 126:429S-456S. 2004
    ..However, in patients without contraindications to anticoagulation, we suggest beginning IV heparin or low molecular weight heparin at presentation (Grade 2C)...
  16. ncbi PA catheter-guided therapy does not benefit critically ill patients
    James E Dalen
    Am J Med 118:449-51. 2005
  17. ncbi Economy class syndrome: too much flying or too much sitting?
    James E Dalen
    Arch Intern Med 163:2674-6. 2003
  18. ncbi Is aspirin resistance due to noncompliance?
    James E Dalen
    Arch Intern Med 168:550; author reply 550. 2008
  19. ncbi Venous thromboembolism and the Archives of Internal Medicine, 1908 to 2005
    James E Dalen
    Arch Intern Med 168:14-5. 2008
  20. ncbi Aspirin resistance: is it real? Is it clinically significant?
    James E Dalen
    Am J Med 120:1-4. 2007
  21. ncbi New PIOPED recommendations for the diagnosis of pulmonary embolism
    James E Dalen
    Am J Med 119:1001-2. 2006
  22. ncbi Use of aspirin as primary prevention of cardiovascular events
    James E Dalen
    JAMA 296:391; author reply 391-2. 2006
  23. ncbi A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study)
    Robert J Goldberg
    Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA
    Am J Cardiol 94:1373-8. 2004
    ..Given the magnitude of AMI and evolving approaches to manage it, continued monitoring of these trends remains of considerable clinical and public health importance...
  24. ncbi Challenges in the diagnosis of acute pulmonary embolism
    Paul D Stein
    Department of Research, St Joseph Mercy Oakland Hospital, Pontiac, Mich, USA
    Am J Med 121:565-71. 2008
    ..A patient-specific approach to the diagnosis of pulmonary embolism can be taken safely in hemodynamically stable patients to increase efficiency and decrease cost and exposure to radiation...